Amneal Pharmaceuticals Executive and Leadership Team

Hiral Kuvadia, the Chief of Staff To President at Amneal Pharmaceuticals, manages the strategic priorities and daily operational flow for the executive office. Coordinating cross-functional initiatives, the Chief of Staff To President ensures that organizational goals align with the broader mission of delivering essential medicines. This role involves synthesizing data from various departments to support informed decision-making by the President. By facilitating communication between the C-suite and internal teams, Hiral Kuvadia optimizes organizational efficiency and project execution. The Chief of Staff To President also monitors the progress of key investments in production capabilities and scientific research. Through meticulous oversight of corporate initiatives, Kuvadia enables the company to maintain a competitive edge in the global pharmaceutical landscape. The Chief of Staff To President consistently drives alignment across the enterprise, ensuring that every strategic objective supports the long-term growth and accessibility goals of the organization.

Upendra Singh, the President, Business & Emerging Markets (India) at Amneal Pharmaceuticals, architects the expansion strategy for high-growth regions. Overseeing the development of commercial infrastructure in emerging markets, the President, Business & Emerging Markets (India) identifies opportunities to broaden the portfolio of essential medicines. This leadership role involves navigating complex regulatory environments and building local partnerships to increase market penetration. By focusing on the unique needs of these geographies, Upendra Singh drives revenue growth and enhances the availability of affordable healthcare solutions. The President, Business & Emerging Markets (India) also collaborates with global leadership to integrate regional insights into the overall corporate strategy. Through targeted investments in local distribution networks, Singh strengthens the presence of the company in critical international sectors. The President, Business & Emerging Markets (India) ensures that operational scaling remains consistent with the high standards of quality and scientific rigor expected by the global organization.

Sanjay Jain, the President, Amneal (India) at Amneal Pharmaceuticals, oversees the core manufacturing and operational activities within the Indian subcontinent. Directing the production capabilities and scientific teams, the President, Amneal (India) ensures that the facility output meets the global demand for generics and complex injectables. This leadership role involves managing large-scale workforce development and employee well-being programs to foster a culture of innovation. By optimizing manufacturing processes, Sanjay Jain drives operational efficiency and cost-effectiveness across the supply chain. The President, Amneal (India) also coordinates with the global executive team to align local production targets with international market requirements. Through the implementation of advanced technology and rigorous quality control, Jain supports the mission of making healthy possible. The President, Amneal (India) consistently delivers results that bolster the global portfolio, ensuring that the company remains a leader in the pharmaceutical industry through superior production and operational excellence.

Jatin Savani, the Sr. General Manager - Global Quality Management (Compliance, Supplier Quality, External Manufacturing and Chief Marketing Officer, SETE) at Amneal Pharmaceuticals, directs the comprehensive quality assurance frameworks across all manufacturing sites. Overseeing global compliance standards, the Sr. General Manager - Global Quality Management (Compliance, Supplier Quality, External Manufacturing and Chief Marketing Officer, SETE) ensures that every product meets rigorous regulatory requirements for essential medicines. This leadership role involves managing complex supplier relationships and optimizing external manufacturing partnerships to maintain supply chain integrity. By aligning marketing strategies with quality outcomes, Jatin Savani drives the commercial success of the SETE division. The Sr. General Manager - Global Quality Management (Compliance, Supplier Quality, External Manufacturing and Chief Marketing Officer, SETE) also coordinates with the Board to mitigate operational risks. Through these efforts, Savani secures the reputation of the company as a reliable provider of affordable, high-quality pharmaceutical products in diverse international markets.